Michael E. Nursey - 17 Feb 2026 Form 4 Insider Report for Amerant Bancorp Inc. (AMTB)

Reporting relationship: SEVP, Chief Domestic Banking Officer
Issuer ticker: AMTB
Reported as of: 17 Feb 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Feb 2026, 18:38:52 UTC
Prior SEC filing: 20 Feb 2026
Next SEC filing: 20 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Julio Pena, as Attorney-in-Fact for Michael E. Nursey

Key filing fact

Michael E. Nursey filed Form 4 for Amerant Bancorp Inc. (AMTB) on 19 Feb 2026.

Key facts

This page summarizes Michael E. Nursey's Form 4 filing for Amerant Bancorp Inc. (AMTB).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 19 Feb 2026, 18:38.

Change

Previous filing in this sequence was filed on 20 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002098589 Primary reporting owner

Nursey Michael E.

Relationship: SEVP, Chief Domestic Banking Officer
Address: C/O AMERANT BANCORP INC., 220 ALHAMBRA CR., 12TH FLOOR, CORAL GABLES
Signature: /s/ Julio Pena, as Attorney-in-Fact for Michael E. Nursey
Signature date: 19 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AMTB transaction Derivative

Restricted Stock Units LTI 2026

Award

Transaction value: $0
Shares: +5,939
Change %
Price: $0.000000
Shares after: 5,939
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 5,939
Exercise price: $0.000000
Footnotes: F1, F2

AMTB transaction Derivative

Performance Based Restricted Stock Units LTI 2026

Award

Transaction value: $0
Shares: +5,939
Change %
Price: $0.000000
Shares after: 5,939
Date: 17 Feb 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 5,939
Exercise price: $0.000000
Footnotes: F3, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each restricted stock unit ("RSU") is the economic equivalent of one share of Class A Common Stock.

Footnote F2

On February 17, 2026, Mr. Nursey was awarded 5,939 RSUs, each representing the right to receive, following vesting, one share of Class A Common Stock. The award vests in substantially equal installments on each of the first three anniversaries of the date of grant, provided that Mr. Nursey remains in the continuous service of the Company or a subsidiary through each such date.

Footnote F3

Each performance-based restricted stock unit ("PSU") is the economic equivalent of one share of Class A Common Stock.

Footnote F4

PSUs awarded to Mr. Nursey, each representing the right to receive, following vesting, one share of Class A Common Stock. The actual number of PSUs earned shall be based on the achievement of the Relative Adjusted Return on Average Tangible Common Equity at a Threshold, Target or Maximum level set by the Compensation and Human Capital Committee (the "Committee") further modified by the achievement of specified Threshold, Target or Maximum levels set by the Committee of Relative Total Shareholder Return for a 3-year period beginning January 1, 2026 and ending on December 31, 2028, and in general can range from 40% to 180% of the PSUs. The number reported reflects the target number of PSUs Mr. Nursey may earn.

SEC remarks

SEVP, Chief Domestic Banking Officer